Selicrelumab (Anti-TNFRSF5 / CD40)

Selicrelumab (anti-TNFRSF5 / CD40) is a human immunoglobulin G2 (IgG2) monoclonal antibody agonist of the cell surface receptor CD40 with potential immunostimulatory and antineoplastic activities. It induces changes in the tumor microenvironment and can be used for the research of pancreatic cancer and neoadjuvant tudies. MW: 146.2 kD.

• Supplier: Selleck Chemicals
• Product #: A2759
• Sku #: A2759-1mg*25